{"id":754867,"date":"2023-05-04T09:20:03","date_gmt":"2023-05-04T13:20:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/"},"modified":"2023-05-04T09:20:03","modified_gmt":"2023-05-04T13:20:03","slug":"better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/","title":{"rendered":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023"},"content":{"rendered":"

<\/p>\n

Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023<\/b><\/p>\n

SAN FRANCISCO–(BUSINESS WIRE<\/a>)–Better Therapeutics, Inc<\/a>. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its first quarter 2023 financial results before the market opens on Thursday, May 11, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET \/ 5:30 a.m. PT on Thursday, May 11, 2023.<\/p>\n

\nTo access the conference call, please register at: https:\/\/register.vevent.com\/register\/BI5d9690c447df48b2b930b971560acd4f<\/a>. Upon registering, each participant will be provided with call details and access codes. All participants are encouraged to join 10 minutes prior to the start time. The live webcast may be accessed by visiting the event link at: https:\/\/edge.media-server.com\/mmc\/p\/khcj9g2y<\/a>. Following the webcast, a replay of the webcast may be accessed from the Presentations & Events page in the Investors section of the Better Therapeutics corporate website at: https:\/\/investors.bettertx.com<\/a>.<\/p>\n

About Better Therapeutics<\/b><\/p>\n

\nBetter Therapeutics is a prescription digital therapeutics company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The CBT delivered by Better Therapeutics\u2019 PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics\u2019 clinically validated mobile applications, if authorized for marketing, are intended to be prescribed by physicians and reimbursed like traditional medicines.<\/p>\n

\nFor more information visit: bettertx.com<\/a><\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230504005506\/en\/<\/a><\/span><\/p>\n

Investor Relations:
\n<\/b>
Mark Heinen
\n
IR@bettertx.com<\/a><\/p>\n

Media Enquiries:
\n<\/b>
Emma Williams
\n
emma.williams@bettertx.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Neurology Cardiology Biotechnology Pharmaceutical General Health Health Diabetes Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its first quarter 2023 financial results before the market opens on Thursday, May 11, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET \/ 5:30 a.m. PT on Thursday, May 11, 2023. To access the conference call, please register at: https:\/\/register.vevent.com\/register\/BI5d9690c447df48b2b930b971560acd4f. Upon registering, each participant will be provided with call details and access codes. All participants are … <\/p>\n

Continue reading “Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754867","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBetter Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its first quarter 2023 financial results before the market opens on Thursday, May 11, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET \/ 5:30 a.m. PT on Thursday, May 11, 2023. To access the conference call, please register at: https:\/\/register.vevent.com\/register\/BI5d9690c447df48b2b930b971560acd4f. Upon registering, each participant will be provided with call details and access codes. All participants are … Continue reading "Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T13:20:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023\",\"datePublished\":\"2023-05-04T13:20:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/\"},\"wordCount\":371,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/\",\"name\":\"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-05-04T13:20:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/","og_locale":"en_US","og_type":"article","og_title":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 - Market Newsdesk","og_description":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced it will release its first quarter 2023 financial results before the market opens on Thursday, May 11, 2023. Management will host a conference call and webcast to provide a business update at 8:30 a.m. ET \/ 5:30 a.m. PT on Thursday, May 11, 2023. To access the conference call, please register at: https:\/\/register.vevent.com\/register\/BI5d9690c447df48b2b930b971560acd4f. Upon registering, each participant will be provided with call details and access codes. All participants are … Continue reading \"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T13:20:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023","datePublished":"2023-05-04T13:20:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/"},"wordCount":371,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/","name":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-05-04T13:20:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230504005506r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/better-therapeutics-to-release-first-quarter-2023-financial-results-and-provide-business-update-on-may-11-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754867"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754867\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}